Holen Sie sich die Stockscreener-App
9.95
1.12%
0.11
Handel nachbörslich:
9.95
Schlusskurs vom Vortag:
$9.84
Offen:
$9.82
24-Stunden-Volumen:
752.59K
Relative Volume:
0.50
Marktkapitalisierung:
$887.22M
Einnahmen:
$-249.00K
Nettoeinkommen (Verlust:
$-187.60M
KGV:
-3.98
EPS:
-2.5
Netto-Cashflow:
$-201.88M
1W Leistung:
+5.63%
1M Leistung:
+25.00%
6M Leistung:
+230.56%
1J Leistung:
+376.08%
1-Tages-Spanne:
$9.71
$10.00
1-Wochen-Bereich:
$9.145
$10.06
52-Wochen-Spanne:
$2.09
$10.06
Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile
Firmenname
Amylyx Pharmaceuticals Inc
Sektor
Branche
Telefon
617-683-0917
Adresse
43 THORNDIKE STREET, CAMBRIDGE
Vergleichen Sie AMLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMLX
Amylyx Pharmaceuticals Inc
|
9.95 | 889.89M | -249.00K | -187.60M | -201.88M | -2.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-06-24 | Eingeleitet | Guggenheim | Buy |
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2025-05-30 | Eingeleitet | TD Cowen | Buy |
| 2025-04-07 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-11-18 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-03-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2024-03-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-03-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-03-08 | Herabstufung | Goldman | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-07-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-01-05 | Eingeleitet | BofA Securities | Buy |
| 2022-05-25 | Eingeleitet | Citigroup | Buy |
| 2022-04-01 | Herabstufung | Goldman | Buy → Neutral |
Alle ansehen
Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten
What’s next for Amylyx Pharmaceuticals Inc. stock priceAnalyst Upgrade & Momentum Based Trading Signals - Newser
What to expect from Amylyx Pharmaceuticals Inc. in the next 30 days2025 Fundamental Recap & Verified Short-Term Plans - Newser
Is Amylyx Pharmaceuticals Inc. stock poised for growthQuarterly Performance Summary & Long-Term Safe Return Strategies - Newser
What is the long term forecast for Amylyx Pharmaceuticals Inc. stockExit Point & Smart Investment Allocation Tips - khodrobank.com
Is Amylyx Pharmaceuticals Inc. building a consolidation baseEarnings Risk Summary & Smart Swing Trading Alerts - Newser
Will Amylyx Pharmaceuticals Inc. see short term momentum2025 Volatility Report & Safe Capital Preservation Plans - Newser
Sector ETF performance correlation with Amylyx Pharmaceuticals Inc.IPO Watch & Free Fast Entry Momentum Trade Alerts - Newser
Live market analysis of Amylyx Pharmaceuticals Inc.July 2025 Outlook & Stepwise Trade Signal Implementation - Newser
Analyzing Amylyx Pharmaceuticals Inc. with risk reward ratio chartsJuly 2025 WrapUp & Daily Volume Surge Signals - Newser
What momentum shifts mean for Amylyx Pharmaceuticals Inc.Market Sentiment Summary & AI Forecast for Swing Trade Picks - Newser
Amylyx Pharmaceuticals Inc. stock trend outlook and recovery pathTrade Risk Report & Weekly Sector Rotation Insights - Newser
Can Amylyx Pharmaceuticals Inc. ride the EV wave2025 Momentum Check & Fast Momentum Entry Tips - khodrobank.com
Amylyx Pharmaceuticals: Strategic Momentum and Pipeline Value in a High-Stakes Biotech Landscape - AInvest
Is this a good reentry point in Amylyx Pharmaceuticals Inc.Earnings Miss & Real-Time Volume Triggers - Newser
Evaluating Amylyx Pharmaceuticals Inc. with trendline analysisQuarterly Profit Summary & Safe Capital Growth Stock Tips - Newser
How sentiment analysis helps forecast Amylyx Pharmaceuticals Inc. - Newser
Can Amylyx Pharmaceuticals Inc. keep up with sector leadersQuarterly Earnings Report & Long-Term Safe Return Strategies - khodrobank.com
Can swing trading help recover from Amylyx Pharmaceuticals Inc. lossesWeekly Profit Report & Fast Moving Stock Watchlists - Newser
Price action breakdown for Amylyx Pharmaceuticals Inc.2025 Top Gainers & Verified Momentum Stock Alerts - Newser
Will Amylyx Pharmaceuticals Inc. benefit from rising consumer demandJuly 2025 Setups & Technical Pattern Alert System - khodrobank.com
What is Amylyx Pharmaceuticals Inc. s debt to equity ratioPortfolio Return Report & Reliable Entry Point Alerts - khodrobank.com
Is Amylyx Pharmaceuticals Inc. stock ready for a breakout2025 Earnings Impact & Short-Term High Return Ideas - Newser
Visual trend scoring systems applied to Amylyx Pharmaceuticals Inc.July 2025 Gainers & Capital Protection Trading Alerts - Newser
How Amylyx Pharmaceuticals Inc. stock performs during market volatilityWeekly Risk Report & AI Powered Market Entry Strategies - Newser
What data driven models say about Amylyx Pharmaceuticals Inc.’s futureCPI Data & Weekly Top Performers Watchlists - Newser
Automated trading signals detected on Amylyx Pharmaceuticals Inc.Market Risk Summary & Daily Profit Focused Stock Screening - Newser
How hedge fund analytics apply to Amylyx Pharmaceuticals Inc. stockEarnings Growth Report & Entry Point Confirmation Alerts - Newser
Order flow analysis tools used on Amylyx Pharmaceuticals Inc.2025 Trade Ideas & Fast Gain Swing Alerts - Newser
What high frequency data says about Amylyx Pharmaceuticals Inc.July 2025 Recap & Advanced Technical Signal Analysis - Newser
Can Amylyx Pharmaceuticals Inc. recover in the next quarterM&A Rumor & High Accuracy Swing Trade Signals - Newser
Can technical indicators confirm Amylyx Pharmaceuticals Inc.’s reversalJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - Newser
Finanzdaten der Amylyx Pharmaceuticals Inc-Aktie (AMLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Amylyx Pharmaceuticals Inc-Aktie (AMLX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mazzariello Gina | Chief Legal Officer |
Aug 12 '25 |
Sale |
8.07 |
15,000 |
121,102 |
171,969 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):